- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04336033
Validation and Evaluation of a Newly Developed Mobile Diet App
Validation and Evaluation of a Newly Developed Mobile Diet App for Enhancing Dietary Adherence for Patients With Chronic Kidney Disease (CKD)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
General Objective: To evaluate a newly developed mobile diet app in enhancing dietary adherence for patients with chronic kidney disease.
Specific Objectives:
- To validate the newly developed mobile diet app for patient with chronic kidney disease.
- To determine the feasibility and acceptability of this newly developed mobile diet app among patients with chronic kidney disease.
- To evaluate the preliminary efficacy of the newly developed mobile diet app in enhancing dietary adherence in patients with chronic kidney disease
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Nor Fadhlina binti Zakaria, Nephrologist
- Phone Number: +603 8947 2561
- Email: fadhsara@yahoo.com
Study Locations
-
-
Selangor
-
Serdang, Selangor, Malaysia, 43000
- Recruiting
- Hospital Serdang
-
Contact:
- Nor Fadhlina binti Zakaria, Nephrologist
- Phone Number: +603 8947 2561
- Email: fadhsara@yahoo.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Clinically diagnosed CKD / eGFR < 60 ml/min/1.73m2 for ≥ 3 months (only applicable to pre-dialysis patients.
- Undergone maintenance dialysis for at least 3 months (only applicable to dialysis patients)
- Possessing smartphone and is willing to use health app
- Alert and oriented
- At least 18 years of age
Exclusion Criteria:
- Inability to use the smartphone app (e.g. due to vision problems)
- Hard to comply with home monitoring (e.g. suffering from anxiety or depression)
- Refuse to comply with dietary prescription
- Patients who participate in other study at the same time
- Patients who have participated in another research study involving an investigational product in the past 12 weeks preceding enrollment.
- Planning for kidney transplant over the study duration.
- Female patients who are pregnant, lactating or planning a pregnancy during the course of the trial.
- Participants who are receiving nutritional support (i.e. enteral and intra-venous route).
- Participants who are currently receiving active treatment for cancer
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Counseling + Renal Diet App
Subjects in the intervention group will receive an individualized dietetic counseling from the researcher aided with the newly developed renal diet app for educative purpose and aiding tool to enhance the dietary adherence among CKD patients
|
Subjects in the both arms will receive individualized dietetic counseling as the standard dietetic care in Malaysia
Individualized dietetic counseling aided with a newly developed renal diet app for educative purpose and aiding tool to enhance the dietary adherence among CKD patients.
Training on the use of the app will be provided to the subjects prior to the commencement of the intervention.
Subjects will be trained on the use of the home screen, icons, feedback screens, the process of entering dietary and fluid intake data and selecting portion sizes.
Subjects are considered as competent users when they could correctly record the foods and drinks with correct portion size eaten in the past 24 hours and successfully save the data.
Other Names:
|
|
Placebo Comparator: Counseling + Printed Nutrition Pamphlet
Individualized dietetic counseling aided with printed nutrition pamphlet prepared by Ministry of Health, Malaysia
|
Subjects in the both arms will receive individualized dietetic counseling as the standard dietetic care in Malaysia
After the counseling session, a standardized renal nutrition pamphlet prepared by dietitians from Universiti Putra Malaysia and Hospital Serdang will be given for patient's educative purpose. Since the mobile application is intended for patient's education and self-monitoring (food diary) purposes, and thus, to ensure the comparability between intervention and control groups, the patients in control group will be trained to record their diet intakes manually using the recommended approach 3-day diet records. Nutritional feedback or advices on the diet records will be given to the participants during follow up sessions. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glomerular Filtration Rate (eGFR)
Time Frame: 3 months
|
Estimated glomerular filtration rate (eGFR) will be recorded in of mL/min/1.73m2.
|
3 months
|
|
Serum Kidney Function Test
Time Frame: 3 months
|
Routine collected biochemical results from the patients' medical records: - urea, sodium, chloride, potassium and creatinine will be measured in mmol/L |
3 months
|
|
Serum Hemoglobin A1C Test
Time Frame: 3 months
|
Routine collected biochemical results from the patients' medical records for HbA1C (%)
|
3 months
|
|
Serum Blood Sugar Profile
Time Frame: 2 weeks
|
Routine collected biochemical results from the patients' medical records and blood sugar (mmol/L) also will be recorded if patient had done self-monitoring blood glucose at home
|
2 weeks
|
|
Albuminuria
Time Frame: 12 weeks
|
Routine collected urine analysis to measure urine albumin (mg) if there is presence of albumin or protein
|
12 weeks
|
|
Dietary History
Time Frame: 6 weeks
|
Three-day diet records (3DDR) : 2 days weekdays + 1 weekend / dialysis and non-dialysis day.
Measured unit is in kilocalories (kcal)/day
|
6 weeks
|
|
Dietary Adherence
Time Frame: 6 weeks
|
End Stage Renal Disease Adherence Questionnaire (ESRD-AQ): - validated questionnaires which consists of 4 subscales pertaining dialysis, medication, dietary and fluid adherences. Patients will need to rate their fluid and dietary adherence on a numerical rating scale which composed of 0% (None of the time) to 100% (All of the time). |
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of the app: interview
Time Frame: 12 weeks
|
The feasibility of the app will be measured by the app usage.
Study participants will be interviewed for app usage in term of frequency (e.g. in average how many days of usage in a week) and extent of its usage (e.g.
how much time has spent on the app in a day).
The intervention (mobile diet app) is consider feasible if the subject used the app more than 50% of study duration which is 42 days (6 weeks).
|
12 weeks
|
|
Acceptability: User Acceptance test (UAT)
Time Frame: 12 weeks
|
Acceptability of the app will be measured using User Acceptance test (UAT).
It consisted of 11 items and each item was rated on a 5-point Likert scale (1 = Strongly disagree, 3 = neutral, and 5 = Strongly agree).
|
12 weeks
|
|
Users Satisfaction: Likert scale
Time Frame: 12 weeks
|
The evaluation questionnaire included 7 items evaluated using a five-point Likert scale (1 = Strongly disagree, 3 = neutral, and 5 = Strongly agree) on the composition of the app, on the design and layout of the app, and overall satisfaction.
|
12 weeks
|
|
Health Behaviour
Time Frame: 12 weeks
|
A set of self-developed items will be used to assess the patient's perceptions of dietary adherence based on HBM constructs.
Content validity have been done by 3 experts with the reported S-CVI/UA of 0.93.
This part consisted of 28 items derived from available literatures, assessing different constructs of HBM
|
12 weeks
|
|
Nutrition Literacy
Time Frame: 12 weeks
|
A dialysis-specific nutrition-related health literacy has been developed based on health literacy theory model (Sørensen et al., 2012) by the researchers and validated among HD patients with the content validity measured by S-CVI/AVE of 0.96 and construct validity measured by average variance extract (AVE) of 0.589 as well as composite reliability of 0.877 (unpublished data).
|
12 weeks
|
|
Nutritional Status
Time Frame: 12 weeks
|
Anthropometry data will be collected by researchers at 2 time points, baseline (V0) and study end-point (V2).
Malnutrition inflammation score (MIS) will be used to assess patient's nutritional status (Kalantar-Zadeh, Kopple, Block & Humphreys, 2001).
|
12 weeks
|
|
Dietary Knowledge
Time Frame: 12 weeks
|
The kidney disease-related dietary knowledge questionnaire was modified from (Durose et al., 2004) based on the Malaysian MNT Guidelines for CKD, (MDA, 2005) which was adopted from the K-DOQI guidelines (NKF 2000; NKF 2003).
|
12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Zulfitri 'Azuan bin Mat Daud, Lecturer[Dr], Universiti Putra Malaysia
- Principal Investigator: Barakatun Nisak binti Mohd Yusof, Lecturer[Dr], Universiti Putra Malaysia
- Principal Investigator: Lim Jun Hao, Dietitian, Universiti Putra Malaysia
Publications and helpful links
General Publications
- Ahmad, G., Leong, G. B., Ngo, L. Y., Meng, O. L., & Guat, L. D. (2016). 24th Report of the Malaysian Dialysis and Transplant Registry 2016. National Renal Registry Malaysia
- Campbell J, Porter J. Dietary mobile apps and their effect on nutritional indicators in chronic renal disease: A systematic review. Nephrology (Carlton). 2015 Oct;20(10):744-751. doi: 10.1111/nep.12500.
- Chan YM, Zalilah MS, Hii SZ. Determinants of compliance behaviours among patients undergoing hemodialysis in Malaysia. PLoS One. 2012;7(8):e41362. doi: 10.1371/journal.pone.0041362. Epub 2012 Aug 3.
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NMRR-19-3569-50972
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Kidney Diseases
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
American Academy of Family PhysiciansUniversity of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaboratorsCompletedChronic Kidney Disease | Chronic Renal Insufficiency | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney Insufficiency, ChronicUnited States
-
Centre Hospitalier le MansLe Mans UniversiteWithdrawnFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage3 | Chronic Kidney Failure | Chronic Kidney Disease, Stage 4 (Severe)
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
-
Centre Hospitalier le MansLe Mans UniversiteRecruitingFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3BFrance
-
University of the State of Santa CatarinaUnknownKidney Diseases | Chronic Kidney Diseases | Hemodialysis | Chronic Renal Insufficiency | Renal Dialysis | Chronic Kidney Insufficiency | Chronic Renal DiseasesBrazil
-
Texas A&M UniversityWithdrawnChronic Kidney FailureUnited States
-
Lund UniversityBaxter Healthcare Corporation; Universidad de CórdobaCompletedEnd Stage Kidney Disease | Chronic Kidney Disease Requiring Chronic DialysisArgentina
-
Benha UniversityCompletedChronic Kidney Diseases | Chronic Kidney Disease 5DEgypt
-
Pharmagest InteractiveCompletedChronic Kidney DiseasesFrance
Clinical Trials on Counseling
-
Tri-Service General HospitalCompletedLung Cancer PatientsTaiwan
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedMalignant NeoplasmUnited States
-
Texas Christian UniversityTerminated
-
Lata Medical Research Foundation, NagpurUnknownMalnutrition in Pregnancy | Other Disorders of Breast and Lactation Associated With ChildbirthIndia
-
King Edward Medical UniversityActive, not recruitingCachexia; Cancer; SarcopeniaPakistan
-
Montefiore Medical CenterRecruiting
-
UKK InstituteFinnish Institute of Occupational Health; Academy of Finland; Vitalmed Research...CompletedEffects of Weight Reduction on Sleep and Alertness in Long-distance Truck and Bus Drivers (SF-Truck)Abdominal ObesityFinland
-
Federal University of São PauloUnknownPain | Myofascial Pain | Facial Pain | Therapeutic Exercise | Temporomandibular Disorder SyndromeBrazil
-
David A KatzAmerican Heart AssociationCompleted
-
Port Said UniversityMansoura University; Prince Sattam Bin Abdulaziz UniversityRecruitingFertility IssuesEgypt